Your browser doesn't support javascript.
loading
Effect of haemodialysis on the pharmacokinetics and pharmacodynamics of evogliptin.
Kim, Byungwook; Im, Dha Woon; Won, Heejae; Sunwoo, Jung; Han, Seung Seok; Lee, Hajeong; Kim, Dong Ki; Oh, Kook-Hwan; Joo, Kwon Wook; Kim, Yon Su; Cho, Joo-Youn; Lee, SeungHwan; Oh, Jaeseong; Jang, In-Jin; Kim, Yong Chul.
Afiliação
  • Kim B; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Im DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Won H; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Sunwoo J; Clinical Trials Center, Chungnam National University Hospital, Daejeon, South Korea.
  • Han SS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Lee H; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Kim DK; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Oh KH; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Joo KW; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Kim YS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Cho JY; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Oh J; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Kim YC; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
Diabetes Obes Metab ; 25(6): 1769-1776, 2023 06.
Article em En | MEDLINE | ID: mdl-36852751
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Dipeptidil Peptidase IV / Falência Renal Crônica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Dipeptidil Peptidase IV / Falência Renal Crônica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Coréia do Sul